Associated Papers
F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B.
Liu G et al.
Blood, 2023
Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma.
Shi Z et al.
Clinical and Translational Medicine, 2021
34047476 (PubMed )
Supplement: CTM2-11-e399-s003.xls › Sheet1
Select a paper to view details